oseltamivir has been researched along with warfarin in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Aceves Baldó, P; Brewster, M; Davies, BE; Lennon-Chrimes, S | 1 |
| Cho, SH; Hong, KS; Jung, JW; Kang, HR; Kwon, JW; Lee, SH; Yu, KS | 1 |
| Kelman, JA; MaCurdy, TE; Mosholder, AD; Racoosin, JA; Shoaibi, A; Wernecke, M; Worrall, C; Young, S | 1 |
| Biondi, E | 1 |
| Abdel-Rahman, SM; Wagner, J | 1 |
| Gambhir, HS; Patel, KM; Shah, SP; Subedi, R | 1 |
| Brown, JN; Bryan, WE; Randolph, AE; Smith, KR; Townsend, ML; Vanderman, AJ; Woodard, CL | 1 |
4 review(s) available for oseltamivir and warfarin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
It doesn't have to be EviDense.
Topics: Adult; Anticoagulants; Antiviral Agents; Child; Evidence-Based Medicine; Humans; Influenza, Human; Integrative Medicine; International Normalized Ratio; Obesity; Oseltamivir; Pain Management; Warfarin | 2014 |
Oseltamivir-warfarin interaction in hypoplastic left heart syndrome: case report and review.
Topics: Anticoagulants; Antiviral Agents; Child; Drug Interactions; Humans; Hypoplastic Left Heart Syndrome; Influenza, Human; International Normalized Ratio; Male; Oseltamivir; Thrombosis; Warfarin | 2015 |
Review of potential drug interaction between Oseltamivir and Warfarin and why it is important for emergency medicine physicians.
Topics: Aged, 80 and over; Anticoagulants; Antiviral Agents; Dose-Response Relationship, Drug; Drug Interactions; Emergency Medicine; Female; Humans; Influenza, Human; International Normalized Ratio; Oseltamivir; Physicians; Pulmonary Embolism; Treatment Outcome; Warfarin | 2017 |
1 trial(s) available for oseltamivir and warfarin
| Article | Year |
|---|---|
Effect of oseltamivir treatment on anticoagulation: a cross-over study in warfarinized patients.
Topics: Aged; Anticoagulants; Antiviral Agents; Blood Coagulation; Cross-Over Studies; Drug Interactions; Factor VIIa; Female; Humans; International Normalized Ratio; Male; Middle Aged; Oseltamivir; Vitamin K 1; Warfarin | 2010 |
5 other study(ies) available for oseltamivir and warfarin
| Article | Year |
|---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Effect of oseltamivir on bleeding risk associated with warfarin therapy: a retrospective review.
Topics: Administration, Oral; Adult; Aged; Anticoagulants; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Hemorrhage; Hospitals, University; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; International Normalized Ratio; Male; Middle Aged; Oseltamivir; Prothrombin Time; Retrospective Studies; Time Factors; Warfarin | 2012 |
Bleeding events following concurrent use of warfarin and oseltamivir by Medicare beneficiaries.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antiviral Agents; Cohort Studies; Drug Interactions; Female; Hemorrhage; Humans; Influenza, Human; International Classification of Diseases; Logistic Models; Male; Medicare; Middle Aged; Multivariate Analysis; Oseltamivir; Pandemics; Retrospective Studies; United States; Warfarin | 2013 |
Impact of prophylactic oseltamivir on INR in patients on stable warfarin therapy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antiviral Agents; Blood Coagulation; Drug Interactions; Drug Monitoring; Female; Hemorrhage; Humans; International Normalized Ratio; Kidney; Male; Middle Aged; Oseltamivir; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; Stroke; Time Factors; Venous Thromboembolism; Warfarin | 2020 |